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Johne's disease (JD), caused by Mycobacterium avium subspecies paratuberculosis (MAP), is endemic in livestock 
leading to low per animal productivity. MAP as survives pasteurization, poses a public health problem because of high 
exposure to animals and humans. There is an urgent need for newer diagnostic tests with high specificity and sensitivity as 
the current ones suffer from lower sensitivity and specificity. In present study, six Mycobacterium avium subspecies 
paratuberculosis (MAP)-specific culture filtrate proteins (CFPs) were produced and evaluated for sero-diagnosis of MAP 
infection in goat and cattle herds in India. Genes encoding for six MAP-CFPs were amplified and cloned into easy cloning 
vector pJET1.2/pTZ57R followed by sub-cloning into expression vector pET28a (+)/pET22b (+) containing C-terminal 
Histidine. Recombinant CFPs (r-CFPs) expressions were optimized in Escherichia coli (Rosetta cells) and purified using  
Ni-NTA affinity chromatography. In SDS-PAGE, MAP CFPs viz., 1693c, 2168c, ModD, 85C, Pep AN and Pep AC showed 
22, 24, 55, 38, 20 and 25 kDa molecular masses, respectively. Identity of these r-CFPs was further confirmed by immuno-
blotting. We developed six different ELISAs using the six individual r-CFPs and one additional ELISA i.e. cocktail ELISA 
(c-ELISA) was prepared using cocktail of all 6 r-CFPs. The performance of all seven ELISAs were further evaluated against 
whole cell protoplasmic based indigenous ELISA (i-ELISA). c-ELISA showed almost similar sensitivity as shown by  
i-ELISA. However, individual r-CFP based ELISA could not reach up to the sensitivity of cocktail of six r-CFPs. None of 
the r-CFP showed any false positive (as compare to i-ELISA) thereby specificity was 100%. Results of ELISA tests based 
on cocktail of r-CFPs, ModD and 85C were quite similar to i-ELISA from goat sera whereas in cattle serum c-ELISA was 
comparable with i-ELISA. Our study showed a comparable specificity of c-ELISA for the diagnosis of JD and it may have 
applicability in region where disease is endemic. Future validation of c-ELISA against gold standard or confirmatory tests 
would give a better insight on its diagnostic potential over i-ELISA.  
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Johne's disease (JD) is chronic incurable 
granulomatous enteritis characterized by persistent or 
intermittent diarrhoea, progressive weight loss, 
debilitation and death
1
. It is caused by Mycobacterium 
avium subspecies paratuberculosis (MAP) that has 














. The disease is endemic in 
livestock leading to low per animal productivity
2
. 
Since MAP gets secreted in milk of affected domestic 
livestock and possibly survives during pasteurization 
as well, with the high exposure to animals and 
humans, it has emerged as a 'public health issue'
7
. 
Diagnostic tests may be helpful in identification and 
elimination of exposed animals in the early stage of 
infection
8
. JD control programs are hampered largely 
due to lower sensitivity and specificity of current 
diagnostic tests. Tests are based on 'antigen detection’ 
(culture, ZN-staining, PCR, in situ hybridization and 
Immunofluorescence), ‘antibody detection’ (Cell 
mediated as well as humoral Immune response) and 
—————— 
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pathology based detection (gross and histopathology). 
Specificity and sensitivity of these tests varies and is 
often not consistent
9
. Therefore, newer diagnostic 
tests with high specificity and sensitivity need to be 
developed.  
 
Culture filtrate proteins (CFPs)/secretary proteins 
are predictable to be immune-reactive or, immune-
dominant due to their occurrence in the extracellular 
environment of cells where they are more possible to 
encounter the sensitized immune cells
10
. Cho et al.
11
 
checked infected serum by immune-blot analysis 
collected from MAP infected cattle, showed strong 
reactivity to CFPs in compare to antigens of 
intracellular origin. Using CFPs for sero-diagnostics 
of MAP, sensitivity of the tests has enhanced and similar 
results came using CFPs of other mycobacteria
12
. As 
compared to conventional ELISAs, the use of CFPs 
led to increase in sensitivity of the antibody detection 
by 20.0%
13
. Studies support the CFPs as better 
antigens for solid-phase ELISA assay performing 
better sensitivity
10,14
. Pradenas et al.
15
 also reported 
that most of the CFPs having low molecular weight 
(>70 kDa) showed strong reactivity with serum from 
culture-positive animals. They have also observed a 
drastic alteration in immune reactivity of CFPs with 
MAP heavy shedders cattle and cattle having clinical 
cases of paratuberculosis. MAP infected small 
ruminants (goats and sheep) serum also displayed 
good reactivity with MAP CFPs examined by 
immune-blot assays
16
. However, selection of antigen 
remains a challenge, since no single CFP based 
antigen can recognize all the stages of infection 
especially sub-clinical infection. The results of earlier 
studies support the use of cocktail of CFPs and it 
could be a better candidate for sero-diagnosis of  
MAP infection. 
 
In the present study, we cloned, expressed, and 
purified six MAP CFPs having potential sero-
diagnostic value. Diagnostic potential of rCFPs were 
assessed by developing the different ELISAs (using 
individual CFP and cocktail of all 6 CFPs) and its 
comparison with whole cell protoplasmic antigen 
(derived from of native MAP strain - ‘S-5 Indian 
Bison Type’) based indigenous ELISA (i-ELISA). 
 
Materials and Methods 
 
Reference strain and sample collection 
MAP reference strain ‘S 5’, 'Indian Bison Type' 
was a novel biotype obtained from Microbiology 
laboratory, Central Institute for Research on Goats 
(CIRG), Makhdoom, Mathura, UP, India. Culture was 
propagated as per standardized protocols
17
. Serum 
samples from 90 goats and 120 cattle were included 
for evaluation of different diagnostic ELISAs. 
Animals were from native livestock breeding farms of 
three states (Uttar Pradesh, Haryana and Madhya 
Pradesh) of India.  
 
Targeted immunogenic CFPs 
In this study, we targeted 6 CFPs encoding genes 
viz. 1693c; 2168c, ModD; 85C; Pep AN and Pep AC 
for cloning, expression, purification and for 
developing ELISA tests. Immunoreactivity of these 
selected CFPs have been demonstrated in earlier 
studies
18
 (Table 1).  
 
Cloning of amplified gene segment of respective CFPs genes 
PCR amplification of CFPs genes 
Genes encoding MAP CFPs were amplified using 
MAP genes specific primers in PCR (Table 2). 
Cycling parameters were: Initial denaturation was 
done at 94C, 5 min., followed by 37 cycles of 
denaturation at 94C, 30 s, annealing at indicated 
temperatures (Table 2) for 30 s, extension at 72C for 
1.0 min, and final extension at 72C for 5 min
17
. 
Amplified PCR products of MAP CFPs genes were 
purified from gel by agrose gel extraction DNA 






Purified PCR products were subjected to restriction 
digestion (Table 2), ligation into appropriate cloning 
vector, followed by transformation (Table 3) and 
plating on ampicilin-containing Luria Bertani (LB) 
agar plates
20
. Positive clones were confirmed by 
restriction digestion and sequence analysis. Products 
Table 1 — Profile of secretome identified as potential antigens in native strain of MAP 
Secretary 
protein 
Putative function Gene size Approx. size of 
protein 
Approx. size of proteins appeared  
with 6 histidine amino acids 
MAP 1693c Peptidyl-prolylcis–trans isomerase 474 bp 19 kDA 22 kDa 
MAP 2168c Hypothetical protein 453 bp 21 kDA 24 kDa 
MAP ModD Fibronectin attachment 998 bp 52 kDA 55 kDa 
MAP 85C Mycolyltransferase 999 bp 35 kDA 38 kDa 
MAP Pep AN Serine proteinase 423 bp 17 kDA 20 kDa 
MAP Pep AC Serine proteinase 540 bp 22 kDA 25 kDa 




were named as pJET-MAP1693c, pJET-MAP2168c, 
pTZ57R/T-Mod D, pTZ57R/T-85C, pJET-MAP Pep 
AN and pJET-MAP Pep AC.  
 
Cloning in the expression vector 
CFP genes were transferred from cloning vector to 
expression vector
20
. Briefly, expression vector 
(pET28a(+) pET22b(+)) was digested with 
appropriate restriction enzyme (Table 2), gel purified 
and dephosphorylated by alkaline phosphatase 
enzyme (Fermentas, USA). Gel purified and 
dephosphorylated vector and respective gene 
fragment (digested from cloned product) were ligated 
using T4 DNA Ligase (Fermentas, USA) and 
transformed into XL-1/XL-10 competent cells 
followed by plating on kanamycin (pET28a 
vector)/ampicillin (pET22b vector) containing LB 
agar plates. Positive clones were confirmed by colony 
PCR and sequencing using T7 universal primer. 
Products were named as pET28a-MAP1693c, 
pET28a-MAP2168c, pET22b-Mod D, pET22a-85c, 
pET28a-MAP Pep AN as well as pET28a- 
MAP Pep. 
 
AC.Expression of recombinant proteins 
To express recombinant CFP proteins, cloned 
constructs (pET28a-MAP1693c, pET28a-MAP2168c, 
pET22b-Mod D, pET22a-85c, pET28a-MAP Pep AN 
as well as pET28a-MAP Pep AC) vectors were 
further transformed into Rosetta competent cells, and 
a single colony for each CFP clone was picked up and 
propagated in 10 mL LB broth supplemented with 
antibiotics {kanamycin/ampicillin (50/100 µg per mL), 
respectively} at 37℃ in shaking mode (200 rpm) for 
16 h. For expression, 500 mL LB broth supplemented 
with antibiotic was inoculated with 1% culture 
(overnight grown) and propagated for 5 h till 
absorbance reached between 0.5-0.6 at 595 nm. Then, 
isopropyl-β-D thiogalactopyranoside {IPTG} was 
added to a optimized concentration of 0.3 mM for 
induction of protein expression. Bacterial cells were 
incubated at indicated time and temperature (Table 4) 
 
Table 2 — Culture filtrate proteins (CFP)s Primers used in the study 
MAP 
Gene 








Forward 5'-GAA TTC ATG GCC GAC TCC TGC CCG ACC GCC-3' EcoRI 474 bp 64°C 
Reverse 5'-CTC GAG CTA GGT CGT GGC GCC GAG GAT C-3' XhoI 
MAP 
2168c 
Forward 5'-GAA TTC ATG GCA GCG CCG ACC GGT CTG C-3' EcoRI 453 bp 66°C 
Reverse 5'-CTC GAG TCA GTT CAT CGC GGT GGC CGC C-3' XhoI 
MAP# 
Mod D 
Forward 5'-CAT ATG GAT CCC GAG GTC CCG ACC-3' NdeI 998 bp 54°C 
Reverse 5'-CTC GAG GGC CGA GAG GGT CTG CTG C-3' XhoI 
MAP 85C Forward 5'-GGA TCC ATG GCG GGT GGC TCC CCC GTC-3' BamHI 999 bp 68°C 
Reverse 5'-AAG CTT TCA GGT GGC GGG CTG GGC C-3’ HindIII 
MAP 
PepAN 
Forward 5'-GGA TCC ATG GCA CCG TCG GGC CTG GC-3' BamHI 423 bp 58°C 
Reverse 5'-CTC GAG TCA GAC GAC CTT GCC GGC CAC C-3' XhoI 
MAP 
PepAC 
Forward 5'-GGA TCC ATG GCG CTC AAC CAG AGC GTC-3' BamHI 540 bp 58°C 
Reverse 5'-CTC GAG TCA GGC CGG CGG CCC CTC C-3' XhoI 
[#Cho et al., 2007ref.18] 
 
Table 3 — Cloning and expression vector and kits, restriction enzyme used in this study 
MAP CFPs 
Gene 
Easy Cloning Cloning in Expression Vector 




Cells used in 
Transformation 
MAP 1693c pJET1.2/blunt vector, CloneJET 









MAP 2168c pJET1.2/blunt vector, CloneJET 









MAP Mod D pTZ57R/T Cloning vector, 
InsTAclone PCR Cloning Kit 
(#1214) 
Ampicillin (100 µg/mL),  








MAP 85C pTZ57R/T Cloning vector, 
InsTA clone PCR Cloning Kit 
(#1214) 
Ampicillin (100µg/mL),  








AP Pep AN pJET1.2/blunt vector, CloneJET 









AP Pep AC pJET1.2 / blunt vector, Clone 
JET PCR Cloning kit (#K1231) 
Ampicillin  












before being harvesting. Both soluble form (medium) 
and inclusion bodies (cell pellet) were assessed for 
optimum production of recombinant protein. 
 
Recombinant MAP proteins that formed 
inclusion bodies (MAP 1693c and MAP 85C) were 
purified as follows: Pellet of Rosetta cells 
harbouring recombinant MAP CFPs were re-
suspended by gentle stirring in 15 mL equilibration 
buffer (50 mM, Tris HCl, 200 mM NaCl, 5 mM 
DTT, 1.0 mM PMSF, pH 8.0). The 15 mL 
suspension was subjected to sonication  
(at optimized conditions). MAP CFPs purification 
was done using affinity chromatography method on 
a Nickel-nitrilotriacetic acid (Ni-NTA) gel matrix 
(Qiagen). A 50 mL conical tube containing 12 mL 
sonicated suspension equilibrated with 1.0 mL Ni-
NTA resin in horizontal position for 8 h at 4C. 
After incubation, the equilibrated suspension of 
MAP CFPs were centrifuged at 515 g, 10 min at 
4C. Supernatants (flow through) were removed 
and pellets were washed thrice with wash buffer  
(50 mM, Tris HCl, 200 mm NaCl, 5 mm DTT, 1.0 
mm PMSF, pH 8.0 and 20 mM Imidazole) and 
supernatant was saved. All recombinant proteins 
was then eluted by increasing concentration of the 
imidazole to 250 mM (50 mM, Tris.HCl, 200 mM 
NaCl, 5 mM DTT, 1.0 mm PMSF, pH 8.0 and  
250 mM). Fractions contained recombinant proteins 
was visualized by SDS-PAGE electrophoresis 
followed by Coomassie brilliant blue staining. For 
purification of soluble proteins (MAP 2168c; MAP Mod 
D; MAP Pep AN and MAP Pep AC), the medium was 
directly subjected to Ni-NTA affinity chromatography. 
The yield of proteins were in the range of 12 mg to 200 
mg/L of bacterial culture (Table 4) 
 
Confirmation, Immuno-reactivity and estimation of recombinant 
proteins 
For confirmation, purified products were run in 
12% SDS-PAGE and subjected to Coomassie blue 
staining to analyze the size of desired products. In 
addition to this, recombinant His-fusion proteins were 
analyzed by Western blot. 
 
Confirmation of proteins and their size 
Nitrocellulose membrane was incubated with 20 mL 
of peroxidase-conjugated anti-His6 peroxidase (Cat. No. 
11965085001, Roche Diagnostic GmBH, Germany) in 
100 mU/mL for 1h at room temperature (25-30C on 
shaker, followed by five times washing with Transfer 
buffer saline with Tween (TBST). Visualization of 
immune-reactive proteins bands were done using 2,3-
diaminobenzidine (DAB) (Sigma-Aldrich). 
 
Measure of the immunoreactivity 
Nitrocellulose membrane was incubated with 20 mL 
of diluted sera (primary antibody) in 1:200 dilution 
and the membrane was kept at 4
◦
C on rocker for over-
night. Further, Nitrocellulose membrane was washed 
thrice using TBST buffer for 10 min. Reactivity was 
recorded by incubating nitro-cellulose membrane with 
per-oxidase-labelled rabbit based anti-species 
(Goat/Cattle) whole IgG antibody (Sigma Aldrich) in 
1:2000 dilutions and incubated for 1.0 h at room 
temperature on rocker, followed by washing with 
TBST five times. Visualization of immunogenic 
proteins bands were completed using 2,3-diamino-
benzidine (DAB) reactivity (Sigma-Aldrich). 
 
Concentration of purified rCFPs 
Concentration of purified rCFPs was estimated 
using Bradford protein estimation method at 595 nm 
using ELISA plate spectrophotometer
21
 (Table 4).  
 
Dot ELISA (d-ELISA) 
Serum based d-ELISA was standardized for CFPs as 
per Singh et al., 2016
22
. Briefly, plastic d-ELISA strips 
(Cat No: CCN-12, MDI, India) were coated with either 
0.5µg in 1.0 µL of standard antigen (MAP 'S 5' strain’) 
used as 'positive control' or individual MAP 
recombinant protein used as 'test antigen'. Antigen-
coated strips were blocked with 3% skimmed milk in 
1XPBS (1h, 37C). Test and positive control antigens 
were reacted with positive and negative control serum 
(1 h at 37C). Rabbit anti-goat HRP conjugate was 
added (30 min at 37C) and finally antigen antibody 
reaction was observed with absence of brown dot by 
adding substrate (DAB). Positive and negative controls 
were used to read the results of two antigens. 
 
Table 4 — Conditions optimized for expressed recombinant CFPs proteins and their concentrations 
Proteins Expression form Temperature and Time Protein concentration Protein quantit/litre of culture 
MAP 1693c Inclusion bodies 30 h at 27C 0.25 µg/µL in 2mL 50 mg 
MAP 2168c Soluble 30 h at 24C 0.12 µg/µL in 2mL 24 mg 
MAP Mod D Soluble 16 h at 37C 0.239 µg/µL in 4mL 92 mg 
MAP 85C Inclusion bodies 30 h at 27C 0.06 µg/µL in 2mL 12 mg 
MAP Pep AN Soluble 16 h at 37C 0.25 µg/µL in 4mL 100 mg 
MAP Pep AC Soluble 16 h at 37C 1 µg/µL in 2mL 200 mg 




Recombinant CFP-based ELISA  
'Indigenous ELISA’ (i-ELISA) using sPPA as 
developed in goats by Singh et al.
23
 and in cattle by 
Sharma et al.
24
 was employed. Either cocktail of 6  
r-CFPs; MAP1693c; MAP 2168c; MAP ModD; MAP 
85C; MAP Pep AN and MAP Pep AC were used at  
6 µg of six r-CFPs (1.0 µg of each r-CFPs) to develop 
cocktail ELISA (c-ELISA); and 6 µg of each individual 
r-CFP to develop recombinant-ELISA (r-ELISA). 
Serum collected from MAP culture positive and 
culture negative animals were used as serum positive 
and serum negative controls, respectively. OD values 
of the samples were expressed as sample to positive 
(S/P) ratios
25
. Animals came positive and strong 
positive categories of the S/P ratios were considered 
positive for MAP infection. Sensitivity and specificity 
of c-ELISA and r-ELISAs were compared with i-
ELISA.   
 
S/P ratio and corresponding status of JD 
S/P ratios revealed corresponding status of JD as 
between 0.00-0.09- Negative (N), 0.1-0.24- 
Suspected/Borderline (S), 0.25-0.39- Low Positive 
(LP), 0.4-0.99- Positive (P) and 1.0-10.0- Strong 
Positive (SP). 
 
Sensitivity and Specificity 
Sensitivity = (True Positive / True Positive + False 
Negative) × 100 
Specificity = (True Negative / True Negative + 
False Positive) × 100 
 
Statistical analysis 
McNemar's test and kappa agreement was used to 
measure the statistical significance between new tests 





Cloning and expression of CFPs 
Genomic DNA was isolated from 'S5' strain of 
novel 'Indian Bison Type' of MAP. Genes encoding 6 
CFPs (MAP1693c; MAP2168c; MAP ModD; MAP 
85C; MAP PepAN and MAP PepAC) were 
successfully amplified (Fig. 1) and cloned into 
pJET1.2/blunt or, PTZ57R/T cloning vector (Fig. 2) 
and then sub-cloned into expression vector viz., 
pET28a (+)/ pET22b(+). Recombinant clones of CFPs 
genes were confirmed by colony PCR, restriction 
digestion and nucleotide sequencing. Purified clones 
(plasmids) were transformed into competent cells  
(E. coli Rosetta) to evaluate expression of r-CFPs. 
Optimum r-CFPs production was observed at 0.3 mM 
IPTG concentration, 24-37
◦
C temperature and 16-30 h 
of incubation (Table 4) and all expressed r-CFPs was 
purified using Ni-NTA resin and confirmed by SDS-
PAGE (Fig. 3). 
 
Comparison of sero-reactivity of six individual r-CFPs and 
their cocktail of six r-CFPs in Immunoblot and dot-ELISA 
system 
SDS-PAGE analysis of purified r-CFPs revealed 
single thick band without detection of any other 
protein band suggesting optimum purity of 
recombinant products. Identity of r-CFPs was further 
assessed in immuno-blotting using anti-His antibody, 
where all the six r-CFPs showed their expected 
molecular mass (Figs. 4 & 5 A-C) except ModD, 
which seemed to be higher (55 kDa) than the expected 
size of 32 kDa. Immunoreactivity of these six r-CFPs 
was measured with positive serum of goats and cattle 
by immunoblot analysis. MAP 1693c, MAP 2168c 
and MAP Mod D, r-CFPs showed similar reactivity  
 
 
Fig. 1 — Amplification of  Six MAP CFPs genes by PCR: M=1kb 
DNA ladder (#SM0313, Fermentas); lane 1= amplified product of 
MAP 1693c (474 bp); lane 2= amplified product of MAP 2168c 
(453 bp); lane 3= amplified product of MAP ModD (998 bp); lane 
4= amplified product of MAP 85C (999 bp); lane 5= amplified 
product of MAP Pep AN (423 bp); lane 6= amplified product of 




Fig. 2 — Easy cloning and confirmation in pJET 1.2 / pTZ57R/T 
vector: M=1kb DNA ladder (#SM0313, Fermentas); lane 1 =Xho I 
and Eco RI digested pJET-1693c; lane 2=Xho I and Eco RI 
digested pJET-2168c; lane 3 = Bam HI and Xho I digested pJET-
Pep AN; lane-4 =Bam HI and Xho I digested pJET-Pep AC; lane 
5= Bam HI and Xho I digested pTZ57R/T.85c; lane 6= Nde I and 
Xho I digested pTZ57R/T.Mod D 





with goats and cattle serum. Whereas, Pep AN and 
Pep AC showed higher reactivity with goat serum and 
85c showed more reactivity in serum of cattle as 
compared to goats (Fig. 5 B & C). All individual 
recombinant CFPs showing good antigenicity by 
individual antigen based dot-ELISA (Fig. 6). 
 
Comparison of sero-reactivity of six individual r-CFPs and 
their cocktail of six r-CFPs with sPPA in ELISA system 
OD values of six individual r-ELISA, cocktail 
ELISA and i-ELISA were expressed as S/P ratio and 
positivity was determined by comparing S/P ratio of 
positive and negative controls
25
 (Table 5). c-ELISA 
showed almost similar sensitivity as shown by  
i-ELISA (Table 6). However, individual r-CFPs based 
ELISA could not reach up to the sensitivity of 
cocktail of six r-CFPs in c-ELISA (Table 6). Sero-
reactivity of individual r-CFPs to positive goat serum 
was in the order of ModD > 85C > 2168c >  
PepAC > PepAN > 1693c (Fig. 7) while in  
 
 
Fig. 3 — Purification of recombinant CFPs: (1) Purification of 
recombinant MAP 1693c protein expressed in Rosetta expression 
strain of E.coli (Left to right): lane 1. Crude sonicated extract, 
lane 2. Supernatant, lane 3. Wash buffer, lane 4. Eluted product, 
lane M: Marker (#SM0671); (2) Purification of recombinant MAP 
2168c protein expressed in Rosetta expression strain of E.coli 
(Left to right): lane M: Marker (#SM0671), lane 1. Crude 
sonicated extract, lane 2. Supernatant, lane 3. Wash buffer, lane 4. 
Eluted product; (3) Purification of recombinant MAP Mod D 
protein expressed in Rosetta expression strain of E.coli (Left to 
right): lane 1. Crude sonicated extract, lane 2. Supernatant, lane 3. 
Wash buffer, lane 4. Eluted product, lane M: Marker (#SM0671); 
(4) Purification of recombinant MAP 85C protein expressed in 
Rosetta expression strain of E.coli (Left to right): lane M: Marker 
(#SM0671), lane 1. Crude sonicated extract, lane 2. Supernatant, 
lane 3. Wash buffer, lane 4. Eluted product; (5) Purification of 
recombinant MAP Pep AN protein expressed in Rosetta 
expression strain of E.coli (Left to right): lane 1. Crude sonicated 
extract, lane 2. Supernatant, lane 3. Wash buffer, lane 4. Eluted 
product, lane M: Marker (#SM0671); (6) Purification of 
recombinant MAP 85C protein expressed in Rosetta expression 
strain of E.coli (Left to right): lane M: Marker (#SM0671), lane 1. 
Crude sonicated extract, lane 2. Supernatant, lane 3. Wash buffer, 
lane 4. Eluted product. 
 
 
Fig. 4 — Purified expressed recombinant CFPs (Right to left): 
lane M= Pre-stained page ladder (#SM0671), lane 1= MAP 1693c 
purified protein, lane 2= MAP 2168c purified protein, lane 3= 
MAP Mod D purified protein, lane 4= MAP 85C purified protein, 
lane 5= MAP Pep AN purified protein, lane 6= MAP Pep AC 
purified protein.  
 
 
Fig. 5 — (A) The four expressed and purified proteins were subjected to immunoblot detection using anti-6 His antibody. (from left to 
right): lane  M- Pre-stained ladder (#SM0671), lane 1- MAP 1693c, lane 2- MAP Mod D, lane 3- MAP Pep AN and lane 4- MAP Pep 
AC; (A1) The two expressed and purified proteins were subjected to immunoblot detection using anti-6 His antibody. (from right to left): 
lane  M- Pre-stained ladder (#SM0671), lane 1- MAP 2168c, lane 2- MAP 85C; and (B & C) Imuunoreactivity of secretory proteins with 
goat & cattle positive serum by Western Blot analysis (from left to right): lane  M- Pre-stained ladder (#SM0671), lane 1- MAP 1693c, 
lane 2- MAP 2168c, lane 3- MAP Mod D, lane 4- MAP 85c, lane 5-MAP Pep AN and lane 6- MAP Pep AC 




cattle it was ModD > 85C > 2168c > 1693c > PepAC 
> PepAN (Fig. 8). 
 
Sensitivity and specificity of recombinant CFPs based ELISA 
in detecting anti-MAP antibodies in comparison to i-ELISA 
Sensitivity of recombinant CFPs based ELISA tests 
was compared with i-ELISA. None of the 
recombinant CFPs reacted to produce false positive 
results thereby considered as 100% specific as 
compared to i-ELISA. However, sensitivity varied 
from 41.4 to 98% in serum of goats and 87.2 to 96.5% 
in bovine serum samples. None of them could provide 
up to 100% sensitivity even with the use of the 
cocktail of six CFPs (Table 6).  
 
The correlation between two different ELISA 
tests was done to detect anti-MAP antibodies, 
sensitivity and specificity, Mc-Nemar calculation as 
well as kappa agreement. Results of ELISA tests 
based on cocktail of r-CFPs, Mod D and 85C were 
quite similar to i-ELISA in detecting anti-MAP 
antibodies in goat sera whereas in cattle serum c-
ELISA was comparable with i-ELISA (Table 7). 
 
 
Fig. 6 — Dot-ELISA test for MAP recombinant CFPs showing 
brown dot for positive samples for MAP infection. (Left to Right): 
lane 1. MAP Pep AC, lane 2. MAP Pep AN, lane 3. MAP 85C, 
lane 4. MAP Mod D, lane 5. MAP 2168c, lane 6. MAP 1693c, 
lane 7. Negative control 2, lane 8. Positive control 2, lane 9. 
Negative control 1, and lane 10. For lane 1 to 6, 8 and 10 positive 
sera was used of MAP infected goats, and for Lane 7 and 9 
negative sera was used from healthy goats. For lane 7 to 10 sPPA 
was used as an antigen. 
 
Table 5 — Screening of goats and cattle serum using sPPA based 
i-ELISA and six recombinant CFPs based six individual r-ELISA 
and a c-ELISA 
Comparison Goats – 90 Cattle – 120 
Positive Negative Positive Negative 
sPPA- i-ELISA 58 32 86 34 
c-ELISA 57 33 83 37 
1693c-ELISA 24 66 77 43 
2168c-ELISA 40 50 78 42 
Mod D-ELISA 56 34 80 40 
85C-ELISA 54 36 79 41 
 Pep AN-ELISA  34 56 75 45 
Pep AC-ELISA 37 53 76 46 
 
Table 6 — Sensitivity and specificity of recombinant CFPs-based 











c-ELISA Goat 57 32 0 1 98.0 & 100.0 
Cattle 83 34 0 3 96.5 & 100.0 
1693c Goat 24 32 0 34 41.4 & 100.0 
Cattle 77 34 0 9 89.5 & 100.0 
2168c Goat 40 32 0 18 69.0 & 100.0 
Cattle 78 34 0 8 90.7 & 100.0 
Mod D Goat 56 32 0 2 96.6 & 100.0 
Cattle 80 34 0 6 93.0 & 100.0 
85C Goat 54 32 0 4 93.1 & 100.0 
Cattle 79 34 0 7 91.9 & 100.0 
Pep AN Goat 34 32 0 24 58.6 & 100.0 
Cattle 75 34 0 11 87.2 & 100.0 
Pep AC Goat 37 32 0 21 63.8 & 100.0 
Cattle 76 34 0 10 88.4 & 100.0 
 
 
Fig. 7 — Preliminary results using the expressed proteins as solid 
phase antigens for screening of sera from goats. [Representative 
results for six individual recombinant proteins based ELISA with 





Fig. 8 — Preliminary results using the expressed proteins as solid 
phase antigens for screening of sera from cattle. [Representative 
results for six individual recombinant proteins based ELISA with 
traditional i-ELISA and c-ELISA (Cocktail of all six recombinant 
secretory proteins)] 





Specific and early diagnosis of MAP infection is a 
major challenge for the control of MAP infection in 
livestock. Increased production of interferon gamma 
in the view of MAP infection is the earliest and first 
immune response (cell mediated), and is slowly 
replaced by response by humoral immunity (antibody 
based)
26
. However, few studies established that some 
elevated level of antibodies is recognized 
considerably earlier and hence serological ELISA 
could also be used as early marker for MAP diagnosis 
in livestock
27
. Selection of the particular early 
secretary protein (antigen) is challenging, since no 
single MAP CFPs can detect all the MAP infected 
animals, especially those in sub-clinical stages of 
disease
28,29
. However, in view of enhanced sero-
reactivity to MAP infected serum, secretary CFPs are 
the focus of research for the development of DIVA 





In the present study, six MAP CFPs known to sero-
react with anti-MAP serum were successfully cloned 
and expressed in bacterial expression system (pET-
28a/pET-22b). Yield (12 mg to 200 mg/L of culture) 
of the purified recombinant proteins was sufficient 
enough to establish ELISA test. No significant 
amount of undesired protein band was observed in the 
purified products suggesting their purity.  However, 
solubility of purified proteins was variable, some of 
them were soluble proteins (MAP 2168c, MAP 
ModD, MAP Pep AN and MAP Pep AC) whereas 
other formed inclusion bodies (MAP 1693c and MAP 
85C). Expressed products were detected in Western 
blot using both anti-His antibody and anti-MAP 
serum suggesting their in-frame fusion as well as 
intact immunoreactivity.  
 
Predicted molecular mass of maximum of the 
recombinant purified CFPs, based on their amino acid 
composition, matched with observations accomplished 
by SDS–PAGE assay and immune-blot analysis. Only 
exception was observed with MAP ModD protein that 
moved slowly in SDS–PAGE than predicted speed. 
This unusual movement pattern was probably due to 
its high proline composition in its peptide sequence, 
and due to this reason we observed the higher 
molecular weight band on SDS-PAGE than expected 
size. 
 
It is rationale to use mixture (cocktail) of MAP-
specific immunogenic CFPs that might upsurge the 
sensitivity and specificity of JD sero-diagnosis. In the 
development of six individual r-ELISA and cocktail 
ELISA, we assessed these six recombinant secretory 
protein antigens (MAP 1693c; MAP 2168c; MAP 
ModD; MAP 85C; MAP Pep AN and MAP Pep AC) 
with i-ELISA. c-ELISA showed almost similar 
sensitivity as shown by i-ELISA (Table 6). Whereas, 
individual r-CFPs based ELISA could not reach up to 
the sensitivity of cocktail of six r-CFPs in c-ELISA 
(Table 6). Results showed that single antigen may not 
be sufficiently sensitive during entire course of 
infection and therefore future experiments with 
cocktails of MAP-specific recombinant protein 
antigens might improve the test sensitivity and enable 
detection of infected animals at different stages of JD. 
Among the six r-CFPs, ModD and 85C revealed high 
sensitivity of 96.6 and 93.1% in goats and 93.0 and 
91.9% in bovine sera, respectively,  while, 1693c, Pep 
AN and Pep AC showed lowest sensitivity of 41.4, 
58.6, 63.8% in goats and 89.5, 87.2 and 88.4% in 
cattle, respectively. 
 
Several other studies supports the sero-diagnostic 
value of CFPs. Dheenadhayalan et al.
32
 has reported 
the immunogenicity of five recombinant antigens 
(rAgs), MAP 2411; ClpP (MAP 2281c); Ppa (MAP 
0435c), MAP 0593c and GreA (MAP 1027c). These 
antigens were tested with serum from MAP infected 
(41) and non-infected (41) control sheep where these 
Table 7 — Statistical evaluation between r-CFP/(s) based ELISA and i-ELISA in detection of MAP infection in goats and cattle 
Recombinant CFP/(s) used in ELISA Relative agreement with i-ELISA  
Goat Cattle 
Kappa 95% CI P value Kappa 95% CI P value 
c-ELISA 0.976±0.024 0.929-1.000 1.000 0.940±0.034 0.873-1.000 0.2482 
1693c 0.334±0.067 0.202-0.466 <0.0001 0.829±0.054 0.723-0.935 0.0077 
2168c 0.612±0.075 0.465- 0.760 <0.0001 0.847±0.052 0.745-0.948 0.0133 
Mod D 0.952±0.033 0.887-1.000 0.4795 0.883±0.046 0.793-0.974 0.0412 
85C 0.906±0.046 0.816-0.996 0.1336 0.865±0.049 0.768-0.961 0.0233 
Pep AN 0.502±0.076 0.354-0.650 <0.0001 0.794±0.058 0.681-0.908 0.0026 
Pep AC 0.556±0.076 0.407-0.705 <0.0001 0.812±0.056  0.702-0.921 0.0044 
[Kappa value (0.0-0.20, poor; 0.21-0.40, fair; 0.41-0.60, moderate; 0.61-0.80, substantial and 0.81-100, perfect); P value showing 0.05 or 
less is considered as significant variation between the two ELISAs; CI: confidence interval] 




antigens, MAP0593c and ClpP, reacted with 58.5% and 
46.3% positive serum and 12.1 and 4.9% of the negative  
serum, respectively. Another study also tested rAgs of 
Ag85A, Ag85B, Ag85C as well as SOD in ELISA with 
serum from 60 MAP shedders and 22 non shedders 
cows
33
. Ag85 complex and SOD were showing high 
reactivity with serum of MAP infected cows and very 
low reactivity with non-infected. Conserved proteins of 
Ag85 complex were observed in all other mycobacterial 
species
34
. At protein level, there were three Ag85 
components were presented in MAP and M. avium 
subspecies avium (MAA) sharing 99% sequence 
identity
35
. Bannantine et al.
36
 have identified 21 potential 
coding sequence of MAP by comparative genomic 
approach. All the 21 genes were successfully cloned and 
five of the 21 genes were only expressed and getting 
purified in its denaturing conditions and examined by 
immune blotting with serum of MAP immunized rabbits 
and mice found immunogenic. Western blot analysis 
with serum of 9 healthy and 10 MAP infected cattle 
showed the same five antigens recognized in context of 
disease. Leroy et al.
37
 have identified 25 antigen 
candidates for diagnosis of MAP infection. They tested 
diagnostic potential of 5 antigens from 25 antigen 
candidates in an ELISA assay with small panel of serum 
collected from fields and their mixture (all three 
antigens) were contested in performance with other 
assays available commercially, getting a diagnostic 
specificity of 97.9% and sensitivity of 94.7%. Mon et 
al.
28
 expressed 54 proteins by recombinant technology 
and spotted on nitrocellulose membrane and gave 
exposure with serum of 25 MAP infected, 10 healthy 
and 8 M. bovis infected animals. Out of 54, only 7 MAP 
antigens (MAP 2513, 1693, 2020, 0038, 1272, 0209c 
and Map 0210c) reacted with serum of MAP infected 
animals. Developed ELISA using Cocktail of these 
antigens reacted with 18 serums of the 25 MAP infected 
animals and did not showed any cross-reactivity with 
healthy animals and showed low reactivity with serum 
from diseased cattle from bovine tuberculosis. Gupta 
et al.
16
 reported that most of the CFPs governs low 
molecular mass (>70 kDa) could be used as potential 
targets for development of new diagnostics for 
paratuberculosis carrying high specificity and improved 
sensitivity in comparison to crude protoplasmic antigens 
(PPA) prepared by sonication of whole cell. Hatamifar 
et al.
38
 have developed a secretary proteins based ELISA 
and evaluated it’s sensitivity and specificity as 70 and 
100%, respectively, which can detect the infection in its 
early stage. In another study, a recombinant MAP 1637c 
(r20.8) protein was used in development of an ELISA 
for the diagnosis of bovine paratuberculosis, reported 
high specificity and sensitivity when compared with the 
PPD skin test
39
. Facciuolo et al.
40
 have identified four 
MAP specific proteins were uniquely reacted with serum 
from MAP infected cows. They demonstrated the 
specificity of these proteins by calf and uninfected cow 
sera containing no detectable antibodies to these 
antigens. So, above reports given by other authors also 
suggest the recombinant CFPs incorporated single 
multiplex (cocktail) ELISA to be valuable for detection 





Six genes encoding MAP CFPs were cloned, 
expressed, purified and evaluated in ELISA to detect 
anti-MAP antibodies in infected animals. While 
sensitivity of individual CFP-based ELISA was low, 
the ELISA developed by cocktail of six recombinant 
CFPs antigen had high sensitivity and it was 
comparable to whole cell protoplasmic i-ELISA. Our 
study shows c-ELISA has comparable specificity than 
i-ELISA and may have better specificity to evaluate 
further against gold standard test and provide a better 
understanding on its diagnostic potential over  
i-ELISA for the diagnosis of JD and it’s applicability 
in region where infection is widespread. 
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